Effect of levamlodipine besylate on vascular function in patients with mild-to-moderate hypertension
Gong Yan-chu
Abstract
Gong Yan-chu
Abstract
Objective To examine the effect of levamlodipine besylate on blood pressure(BP),aortic pulse pressure,aortic augmentation index,brachial-ankle pulse wave velocity in patients with mild-to-moderate hypertension. Methods The study was conducted in seven hospitals(community service centers)in Shanghai,where 253patients(129men and 124women)with a diagnosis of mild-to-moderate essential hypertension based on 24-hour ambulatory BP were recruited. After a washout period of 2weeks,all patients aged from 45to 70(57.6±7.0)years were randomly assigned to the treatment group(levamlodipine besylate:2.5mg/d;n=129)or the control group(amlodipine besylate:5.0mg/d;n=124). After 24-week treatment,changes in BP and parameters of vascular function were assessed. Results Compared with pre-treatment,the clinic,24-hour and central BP were all significantly reduced(P0.01)in the two groups,while there was no substantial difference(P0.05)after 24-week treatment between the two groups. After adjusting for age and body height,compared with pre-treatment,the brachial-ankle pulse wave velocity,aortic pulse pressure,aortic augment index and ambulatory arterial stiffness index were all significantly decreased[(1598.1±238.6)vs(1757.9±338.5)cm/s,(41.9±11.7)vs(49.6±12.2)mm Hg,25.1± 7.9vs 29.0±8.2and 0.41±0.11vs 0.47±0.10]in the levamlodipine besylate group and[(1584.7±226.7)vs(1742.8±228.5)cm/s,(42.6±15.2)vs(50.0±14.6)mm Hg,25.7±7.1vs 29.6±8.2and 0.44±0.11vs 0.49±0.12]in the amlodipine besylate group,respectively. After treatment,there was no significant difference in these parameters between the two groups. No statistically significant difference was also found for ankle-brachial blood pressure index,carotid intima-media thickness and the plaque size after treatment in both groups(P0.05). Conclusions Levamlodipine besylate at 2.5mg/d and amlodipine besylate at 5.0mg/d had the similar effects on the BP reduction and the improvements of vascular function.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To examine the effect of levamlodipine besylate on blood pressure(BP),aortic pulse pressure,aortic augmentation index,brachial-ankle pulse wave velocity in patients with mild-to-moderate hypertension. Methods The study was conducted in seven hospitals(community service centers)in Shanghai,where 253patients(129men and 124women)with a diagnosis of mild-to-moderate essential hypertension based on 24-hour ambulatory BP were recruited. After a washout period of 2weeks,all patients aged from 45to 70(57.6±7.0)years were randomly assigned to the treatment group(levamlodipine besylate:2.5mg/d;n=129)or the control group(amlodipine besylate:5.0mg/d;n=124). After 24-week treatment,changes in BP and parameters of vascular function were assessed. Results Compared with pre-treatment,the clinic,24-hour and central BP were all significantly reduced(P0.01)in the two groups,while there was no substantial difference(P0.05)after 24-week treatment between the two groups. After adjusting for age and body height,compared with pre-treatment,the brachial-ankle pulse wave velocity,aortic pulse pressure,aortic augment index and ambulatory arterial stiffness index were all significantly decreased[(1598.1±238.6)vs(1757.9±338.5)cm/s,(41.9±11.7)vs(49.6±12.2)mm Hg,25.1± 7.9vs 29.0±8.2and 0.41±0.11vs 0.47±0.10]in the levamlodipine besylate group and[(1584.7±226.7)vs(1742.8±228.5)cm/s,(42.6±15.2)vs(50.0±14.6)mm Hg,25.7±7.1vs 29.6±8.2and 0.44±0.11vs 0.49±0.12]in the amlodipine besylate group,respectively. After treatment,there was no significant difference in these parameters between the two groups. No statistically significant difference was also found for ankle-brachial blood pressure index,carotid intima-media thickness and the plaque size after treatment in both groups(P0.05). Conclusions Levamlodipine besylate at 2.5mg/d and amlodipine besylate at 5.0mg/d had the similar effects on the BP reduction and the improvements of vascular function.
Key concepts: Medicine, Pulse wave velocity, Amlodipine, Blood pressure, Pulse pressure, Ambulatory blood pressure, Arterial stiffness, Aortic pressure